Key result
Atorvastatin is linked to more adverse drug reaction reports and serious reactions than other statins.
Why the study?
What are the common and serious adverse drug reactions associated with statin use in a Chinese population?
Observational
What are the common and serious adverse drug reactions associated with statin use in a Chinese population?
Answers are grounded in this paper and cite their sources.
In a Chinese pharmacovigilance database, atorvastatin was associated with a higher number of serious and off-label adverse drug reactions compared to other statins.
INTRODUCTION: Statins, some of the most widely prescribed medications for the treatment of cardiovascular diseases, cause common and serious adverse drug reactions (ADRs). However, studies of statin-related ADRs in the Chinese population are lacking. RESEARCH DESIGN AND METHODS: ADR reports of statins collected by the Hubei Adverse Drug Reaction Monitoring Center from 2014 to 2022 were analyzed. Statin safety was described using descriptive analysis and three signal mining methods: reporting odds ratio, proportional reporting ratio, and a combined standard method. RESULTS: ADRs were common in individuals aged 50-79 years. Most administration routes are oral. ADR reports of atorvastatin and rosuvastatin were numerous and serious. The reports mainly consisted of gastrointestinal disorders, hepatobiliary disorders. Three signal mining algorithms generated 91 identical drug - event combination signals, including 23 off-label ADRs. CONCLUSIONS: Atorvastatin was associated with a higher number of ADR reports and a higher proportion of serious ADRs than the other statins. Atorvastatin may cause off-label ADRs such as back pain, increased blood bilirubin, bone pain, hemorrhage, hepatic failure, and hepatocellular injury. Drug instructions should be enriched for better labeling of ADRs.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) conducted an observational in Statin-related adverse drug reactions. Statins (atorvastatin, rosuvastatin) vs. Other statins was evaluated on Adverse drug reactions and drug-event combination signals. Atorvastatin was associated with a higher number of adverse drug reaction reports and a higher proportion of serious reactions than other statins, including 23 off-label adverse drug reactions.
Synapse has enriched 10 related papers. Consider them for comparative context: